The mechanisms involved in the selective joining of appropriate 5' and 3' splice sites are still poorly understood in both constitutive and alternatively spliced genes. With two promoters associated with different exons, the myosin light-chain 1/3 gene generates two pre-mRNAs that also differ by the use of a pair of internal exons, 3 and 4 , that are spliced in a mutually exclusive fashion. When the promoter upstream from exon 1 is used, only exon 4 is included. If the promoter upstream from exon 2 is used, only exon 3 is included. In an attempt to understand the molecular basis for the mutually exclusive behavior of these two exons and the basis of their specific selection, a number of minigene constructs containing exons 3 and 4 were tested in a variety of homologous or heterologous cis and trans environments. The results demonstrate that the mutually exclusive behavior of myosin light-chain exons 3 and 4 and selection between the two exons are cis regulated and are affected by the nature of the flanking sequences. Both exons competed for the common flanking 5' and 3' splice sites. Flanking exons were found that favored inclusion into mature mRNA of exon 3, exon 4, both, or neither, suggesting a specific cooperative interaction between certain 5' and 3' splice sites. Thus, alternative splicing of myosin light-chain 1/3 pre-mRNAs is regulated in cis by a hierarchy of compatibilities between pairs of 5' and 3' splice sites.
In higher eucaryotes most genes produce pre-mRNAs containing intervening sequences that have to be removed to generate mature mRNAs. Three sequence elements have been found to be required for splicing: the 5' and 3' splice sites at each end of the intron and the branch point sequence (BPS) commonly located between 20 and 40 nucleotides (nt) upstream of the 3' exon (17, 38, 51) . Recent results strongly suggest that the 5' splice site and the BPS and its polypyrimidine tract are the two most important landmarks in the intron (17, 38, 43, 53, 55) . (For reasons of simplicity from here on we will refer to the BPS, polypyrimidine tract, and acceptor site together as the 3' splice site.) These sequence elements interact with splicing factors to form a large complex, termed the spliceosome (5, 10, 15) , that involves the interaction of small nuclear ribonucleoproteins and a number of other proteins with the pre-mRNA (29, 31) .
One of the main unsolved problems in splicing is understanding the mechanism by which the splicing machinery precisely recognizes the correct 5' and 3' splice sites to be joined together. This is so because the sequences conforming to the 5' and 3' splice site consensus sequences are redundant and can be found repeated within introns and exons (37, 50) . These cryptic sites, however, are not used unless the bona fide splice site is mutated (17, 38) . Thus, questions arise as to how a functional splice site is defineda consensus sequence is obviously not sufficient-and also as to the mechanism that restricts the pairing of the correct donor and acceptor.
Different sequence elements have been suggested to play a role in splice site selection, including secondary structure of the mRNA (8, 56, 57) and the degree of match to the consensus 5' splice site and BPS (1, 36, 43, 63, 64) . These elements, however, by themselves cannot account for the accuracy and efficiency of the splicing process. This problem * Corresponding author.
becomes even more complex in the case of alternatively spliced transcripts (2, 4, 54) . In such cases, proximal functional splice sites are sometimes bypassed in favor of more distal ones. In most cases, this bypass is regulated in a tissue-and/or developmental stage-specific manner. Striking examples of such alternative splicing are exhibited by genes with pairs of mutually exclusive exons. In such pairs, only one of the exons in the pair is included in the mature mRNA, whereas the other one is excluded. For genes with mutually exclusive exon pairs, no cellular mRNAs have yet been detected that incorporate both exons, despite the fact that the introns between them contain functional 5' and 3' splice sites. An understanding of this mode of alternative splicing requires an explanation, first, for the inability of the two exons to be spliced together and, second, for the basis of the cell-and developmental stage-specific selection. In the case of the a-tropomyosin (a-TM) exons 2 and 3 (53) , the mutually exclusive behavior is due to the proximity of the BPS upstream of exon 3 to the donor of exon 2, which at 41 nt absolutely prevents splicing complex formation by steric interference. It is not clear, however, whether this is a general mechanism to enforce mutually exclusive behavior or whether it is limited to this pair of exons. Moreover, there are cases of mutually exclusive splicing of pre-mRNAs originating from complex transcription units that have different 5' or 3' sequences, each associated with a particular splicing pattern (2, 40, 45) . In these cases each transcript has only one splicing pathway available to it. It is possible that the splicing pattern of these mRNAs is regulated entirely in cis through the structure of the pre-mRNA and determined by promoter or poly(A) addition site choice.
We are interested in testing the generality of the mechanisms uncovered for a-TM exons to gain insight into the regulation of mutually exclusive splicing of pre-mRNAs with different primary structures. For this reason we have analyzed the splicing pattern of the two mutually exclusive exons of the rat skeletal alkali myosin light-chain (MLC) 1/3 gene (MLC1/3). This gene generates two pre-mRNAs differing in length and sequence, through the use of two different promoters (40, 58) . The two transcripts have different 5' exons and are spliced in a transcript-specific manner to generate MLC1 or MLC3 mRNAs through the mutually exclusive splicing of exons 4 and 3, respectively.
Here, we show that both the mutually exclusive behavior and the choice between MLC1/3 exons 3 and 4 is cis regulated by local sequences in the vicinity of these exons. In contrast to a-TM exons 2 and 3, MLC1/3 exons 3 and 4 are able to splice together in the absence of competition from flanking splice sites. There is a competition between the two exons for the flanking splice sites, and deletion of the preferred exon results in inclusion of the normally excluded one. Interestingly, the nature of the flanking exons plays a role in the selection of exon 3 or 4. Flanking exons were found that favored inclusion into the mature mRNA of exon 3, exon 4, both, or neither, suggesting some form of specific cooperative interaction between certain donor and acceptor sites. These results strongly suggest that alternative splicing of MLC1/3 pre-mRNAs is regulated in cis by a hierarchy of compatibilities between specific pairs of 5' and 3' splice sites.
MATERIALS AND METHODS
Plasmid constructions. Plasmids constructs containing MLC1/3 genomic sequences were prepared by standard procedures (28) . MLC clones were derived from the genomic clone XLCH14 (40) . pSVpA is a pUC18-based vector that carries the simian virus 40 (SV40) promoter-enhancer element from prI2-SV40-46 (25) linked to the 671-base-pair PstI-BamHI fragment containing the 3' end of the SV40 large T antigen via a unique HindIll site. pSVLC2345 is pSVpA containing a 7.5-kilobase HindIII fragment from XLCH14 that includes MLC exons 2, 3, 4, and 5. This fragment includes 800 base pairs of the intron 5' to exon 2, which contains the MLC3 promoter, and 1,700 base pairs of the intron 3 20 ,g) with a probe (5 x 104 cpm) was in 80% formamide-400 mM NaCl-10 mM piperazine-N,N'-bis(2-ethanesulfonic acid)-0.5% sodium dodecyl sulfate-1 mM EDTA. The hybridization mixture was heated for 1 h at 65°C and then allowed to cool to 38°C overnight. S1 digestion was carried out for 1 h at 25°C with 60 U of S1 nuclease. Nuclease-resistant fragments were separated by denaturing polyacrylamide gel electrophoresis and detected by autoradiography.
In vitro splicing and RNA analysis. Transcripts for in vitro splicing were prepared with SP6 polymerase as previously described (33, 41, 47) . HeLa cell nuclear extracts were prepared by the method of Dignam et al. (6) . Splicing reactions were carried out as described by Krainer et (Fig. 1) . The two promoters are separated by 10 kilobases, giving rise to two primary transcripts very different in length and sequence (40, 58 the production of MLC3 mRNA. MLC1/3 exons 3 and 4 are therefore mutually exclusive. The two promoters are expressed exclusively in skeletal muscle and are developmentally regulated. MLC1 is induced at the late embryonic stage, and MLC3 is induced in the early postnatal stage. Both are expressed simultaneously in adult muscle (40) .
Three possible mechanisms could account for the developmental and tissue-specific patterns of splicing of MLC1/3 gene. First, the developmental and tissue-specific switches would be easily understood if each pre-mRNA were committed to a specific splicing pattern, dictated by the primary structure of the transcript. Different RNA folding of these two widely different transcripts could dictate exon selection by differentially masking or exposing certain splice sites. Alternatively, the mutually exclusive behavior of MLC exons 3 and 4 could be locally determined by their flanking sequences, with the choice of one or the other being determined by the nature of the 5' donor splice sites in the transcript. Transcripts with the donor of exon 1 would select exon 4, whereas in the absence of this exon, the donor of exon 2 would select exon 3. According to both hypotheses, the splicing pattern would be transcriptionally regulated. Changes in promoter utilization would be sufficient to produce the observed phenotype. A final possibility is the involvement of muscle-specific trans-acting factors enforcing the mutually exclusive behavior. In the absence of these factors the pre-mRNAs would be spliced in a constitutive manner. The fact that MLC1 and MLC3 mRNAs are produced by the same cell strongly suggests that the choice between the alternative exons is regulated in cis and not dependent on trans-acting factors.
To test these hypotheses, we designed a number of minigene constructs in which different combinations of exons 3 and/or 4 were placed in a variety of homologous and heterologous cis and trans environments. These constructs were placed under the control of the SV40 enhancer-promoter and poly(A) processing signal sequences to allow expression in muscle and nonmuscle cells. After transfection into various cell lines, the splicing patterns of the transcripts were analyzed by S1 nuclease protection of total cytoplasmic RNA. As probes we used synthetic oligonucleotides that contained the proper diagnostic sequences.
Using this approach, we first sought to determine whether local sequences were sufficient to dictate the mutually exclusive splicing and to ascertain whether muscle-specific factors were required for this behavior. To this end a DNA fragment containing exons 2, 3, 4, and 5 and the intact introns between them was introduced into the SV40 expression vector to generate pSVLC2345. The DNA was transfected into COS cells, and the RNA was analyzed by Si nuclease protection. A synthetic oligonucleotide probe containing the sequences of the four exons was used to analyze the transcripts. The only mRNA produced in COS cells corresponded to the MLC3 mRNA, in which exons 2, 3, and 5 were spliced together with the exclusion of exon 4 (Fig. 2) . No splicing products corresponding to MLC1 mRNA, defined by the splicing together of exons 4 and 5, were produced. The rat skeletal muscle RNA used as a control contained both mRNAs, as expected. No RNAs were detected in which exons 3 and 4 had both been spliced out, either in the muscle or in the transfectants. However, the faint band corresponding to fully protected probe, detected in both muscle and transfected cell RNA, could be due to the presence of a small amount of RNA containing exons 3 and 4 or to protection of the probe by unspliced pre-mRNA (52) .
From this result we conclude that the sequence included in the construct contains the necessary information to specify the mutually exclusive splicing of exons 3 and 4. Sequences downstream from exon 5 are not needed. This process does not require muscle-specific factors and is therefore regulated in cis. Although COS cells do not normally express the MLC1/3 gene, they are able to splice its transcripts in a manner that is indistinguishable from that of the muscle cells. Moreover, the presence of exon 2, in the absence of exon 1, is sufficient for the inclusion of exon 3 and exclusion of exon 4. This is the pattern used by muscle cells in the production of MLC3 mRNA.
The choice between the mutually exclusive exons 3 and 4 can be determined by the nature of the exon 5' to them. After determining that a truncated transcript with MLC exon 2 at its 5' end spliced according to the MLC3 mRNA pattern, we tested whether the presence of MLC exon 1 and its proximal intron sequences was sufficient to determine the MLC1 mRNA splicing pattern; that is, inclusion of exon 4 and exclusion of exon 3. Exon 2 in pSVLC2345 was replaced by a DNA fragment containing exon 1 and 362 nt of the first intron to generate pSVLC1345 (Fig. 3) . As expected from the previous results, together with the MLC1 pre-mRNA pattern of splicing in muscle cells, exon 1 was spliced to exon 4. In contrast to the results obtained with pSVLC2345, no mRNA that included exon 3 was detected in cells transfected with pSVLC1345. Therefore, because the two constructs were identical with the exception of their 5' exons, it is fair to conclude that in this sequence context the nature of the 5' exon determines which of the two mutually exclusive exons will be incorporated into the spliced RNA. In the presence of exon 1, exon 4 was included and exon 3 was excluded, whereas in the presence of exon 2, the pattern was reversed. In addition to the correctly spliced RNA, pSVLC1345 produced an RNA that corresponded to the joining of exon 1 to exon 5, bypassing the two mutually exclusive exons (Fig. 3B) . This is not due to the cell type, since the same RNA was produced in transfected C2C12 myotubes (62) , albeit in reduced amounts (Fig. 3A) . The same results were obtained with a construct in which exon 5 was replaced by a cDNA fragment containing exons 5, 6, 7, 8, and 9 (data not shown). That these results were not due to protection of the probe by unspliced RNA (52) was further verified by using two DNA probes containing intervening sequences (Fig. 3B) . One probe contained exon 1 and 288 nt of its 3' intron, whereas the second contained exon 5 and 1,219 base pairs of its 5' intron.
From these results we can conclude that in nonmuscle as well as in muscle cells the minigene constructs can reproduce the MLC gene pattern of splicing. Furthermore, in this context the selection between the two mutually exclusive exons 3 and 4 is determined by the nature of the common 5' splice site.
To determine whether the results obtained with MLC gene exons 1 and 2 were specific to these exons or part of a more general mechanism of splice site selection, MLC exons 3 and 4 were inserted between heterologous pairs of flanking splice sites (Fig. 4) . In pSVlns34, they were inserted into the EcoRI site in the second intron of the rat preproinsulin gene (25) and transfected into nonmuscle cells (COS) as well as undifferentiated and differentiated C2C12 myogenic cells (Fig. 4A) . In all three cell types, a very significant fraction of the RNA detected corresponded to the splicing of insulin exon 2 to MLC exon 4, with skipping of exon 3 (Fig. 4A) . In all cell types, however, a species corresponding to skipping of both exons was detected. In addition, there was also a band corresponding to fully protected probe. Again, this band could represent undigested probe or a small fraction of mRNAs that includes exons 3 and 4 (see below). Identical results were obtained when other muscle (L6E9) (35) and nonmuscle (HeLa) cell lines were used (data not shown). These results are not unique to the insulin gene environment. The same splicing pattern was detected when the alternatively spliced exons were placed between the rat a-TM exons 1 and 4 (Fig. 4B) . These exons also flank a pair of mutually exclusive exons in the native a-TM gene (53, 61) . Therefore, the mutually exclusive behavior of MLC exons 3 and 4 is not dependent on homologous flanking exons. When placed in either the insulin or the a-TM gene environments, the splicing pattern resembled that of MLC1 mRNA. As described above for the homologous constructs, their behavior is independent of cell type and stage of differentiation. Because COS cells mimic muscle cells in the splicing of the MLC exons 3 and 4 and produce significantly larger quantities of transfected RNA, they were used to test the remainder of the constructs to be described below.
MLC exons 3 and 4 are not intrinsically mutually exclusive. The results presented above demonstrate that the mutually exclusive behavior of MLC exons 3 and 4 is determined by the local sequences around them and is preserved in a variety of cis and trans environments. In the case of exons 2 and 3 of the a-TM gene (53, 55) , the mutually exclusive behavior is determined by the intrinsic inability of the two exons to be spliced together due to the abnormal location of the branch point between them. To directly test whether MLC exons 3 and 4 are intrinsically unable to splice to each other for similar anatomic reasons, the in vitro transcription construct shown in Fig. 5 was prepared. RNA was transcribed in vitro by using SP6 polymerase and spliced in a HeLa nuclear extract splicing system (6, 22, 33) . The results clearly show the appearance of the expected splicing intermediates and products with the expected kinetics. The nature of the bands labeled in Fig. 5 was further ascertained by their electrophoretic mobility in different concentrations of acrylamide and their response to a debranching reaction. The splicing of the two exons was confirmed by testing an in vivo expression construct with similar anatomy after trans- fection into COS cells. As expected, spliced RNA containing exons 3 and 4 in the same molecule was detected (data not shown). These results demonstrate that the basis for mutually exclusive behavior of MLC exons 3 and 4 is not an intrinsic inability to be spliced together. In the absence of competition, the intron between them was effectively removed both in vivo and in vitro. As the results described below demonstrate, relative affinity and competition among splice sites but not intrinsic incompatibility are the basis for the alternative splicing of the MLC gene.
Choice between MLC exons 3 and 4 is position independent. It has been shown previously that splice site proximity can be an important determinant in splice site selection. In cis competition assays between duplicated sites, the nearest one is preferred (42) . Splice site selection appears to result from a combination of splice site strength, homology to the consensus sequence, and proximity. The results presented above demonstrate that certain combinations of 5' and 3' splice sites are preferentially joined together. The position of MLC exons 3 and 4 with respect to each other could be an important factor in determining exon choice. To test this possibility, the positions of these exons in pSVTm34 and pSVIns34 (Fig. 4) were reversed to generate constructs pSVTm43 and pSVIns43, respectively (Fig. 6 ). pSVTm43 gave rise to a processed RNA that, as in the case of the parental construct (pSVTm34), included exon 4 but excluded exon 3 (Fig. 6A) . The relative position of the two exons affected neither their mutually exclusive behavior nor the choice between them. Moreover, it is noteworthy that the integrity of the intron between the two exons was not required for mutual exclusivity.
The results obtained with pSVIns43 were more complex (Fig. 6B) . As in pSVIns34, the preferred exon continued to be exon 4, but, in addition, all other possible patterns of splicing were detected. In particular, there was a large amount of RNA containing both MLC exons 4 and 3. The RNA was further tested by using a probe that contained a nonhybridizing tail, so full protection could be distinguished from nondigested probe (data not shown). This result supported the notion, obtained with pSVIns34, that in the insulin gene context exon 4 is preferred over exon 3. In addition, it demonstrated that when splice sites in a transcript are rearranged among different sets of pairs, their relative strengths can be affected significantly. In this particular construct, most of the mutually exclusive behavior was lost. Since this was not the case for pSVTm43, which contained identical MLC gene sequences, it is clear that the nature of the flanking splice sites plays a role in determining the pattern of splicing.
The (Fig. 7) . This is the expected result, since exon 4 was also the preferred exon in the presence of exon 3. In contrast, MLC exon 3, which was completely excluded in MOL. CELL. BIOL. the presence of exon 4, was spliced in when the competition was deleted. The efficiency of splicing of exon 3, even in the absence of competition, was significantly lower than that of exon 4, because at best it constituted less than 50o of total spliced RNA. This result clearly demonstrates the existence of competition between exons 3 and 4 for the common flanking splice sites. In the context of the insulin gene, exon 4 was preferred and outcompeted exon 3. It is interesting to note, however, that pSVIns3 and pSVIns4 and all of the heterologous constructs tested produced spliced RNAs that contained none of the MLC exons. This result suggests that the compatibility between the two splice sites of the flanking exons for each other is higher than that for either of the MLC exons.
The results presented here indicate that the mutually exclusive splicing of MLC exons 3 and 4 is, at least in part, kinetically determined and due to a competition between the two exons for the common flanking sites. This competition is regulated in cis. In the context of the insulin gene, exon 4 was preferred, leading to the exclusion of exon 3, in both muscle and nonmuscle cells. In both cell types, however, exon 3 was recognized at low efficiency, and its inclusion was dramatically increased when exon 4 was deleted. It appears, therefore, that the constitutive splicing machinery is sufficient to govern selection between these two exons.
The pattern of splicing of MLC exons 3 and 4, including their mutually exclusive behavior, is affected by the flanking 3' and 5' common exons. The results presented above demonstrate that the mutually exclusive behavior of MLC exons 3 and 4 is regulated in cis. The choice between the two MLC exons is determined, at least in part, by the nature of the 5' common exon ( Fig. 2 and 3) . Together with the fact that MLC1 and MLC3 pre-mRNAs differ at their 5' ends, it suggests that this is the site that determines the choice between alternative exons. To further investigate this issue and test the role of the 3' common exon, an additional set of constructs was designed. pSVLC234Ins3 and pSVLC234Tm4 were constructed by replacing exon 5 in pSVLC2345 (Fig. 2) with insulin exon 3 and a-Tm exon 4, respectively ( Fig. 8A and B) . As previously described, pSVLC2345 was spliced according to the MLC3 mRNA pattern, including exon 3 and excluding exon 4. However, the two constructs with a 3' exon replacement exhibited a very different pattern of splicing. Both constructs produced RNAs containing all possible combinations of MLC exons 3 and 4. RNAs containing only exon 4 and excluding exon 3 represented a small percentage of the total. RNAs including both exons 3 and 4, only exon 3, or neither were each produced at similar levels. Therefore, the mutually exclusive behavior and the pattern of exon choice was dramatically altered by substituting the 3' common exon. To ascertain that the protected bands were produced by spliced RNA and were not an artifact caused by looping out of the intron in unspliced RNA (52) , the same RNAs were probed with two VOL. 10, 1990 A B C oligonucleotides containing the corresponding exons, part of their intron, and a nonhybridizing tail (Fig. 8C) . The S1 nuclease protection products were 28 and 25 nt long with the 5'-or 3'-labeled probe, respectively. This result excluded the presence of unspliced RNA as the source of the protected bands and demonstrated that MLC exon 3 had been spliced to MLC exon 4.
That the 5' common exons are equally important is demonstrated by the results shown in Fig. 3 and the construct shown in Fig. 9 . This construct (pSVTmlLC345), like the two previous ones, was also derived from pSVLC2345, but in this case MLC exon 2 was replaced by the a-TM exon 1 The results presented herein demonstrate that the mutually exclusive behavior of MLC exons 3 and 4 and their selection are significantly influenced by the nature of the 5'-and 3'-flanking common exons (Fig. 10) . A given 5' or 3' splice site exhibited dramatically different efficiencies of splicing, depending on the nature of its partner. These efficiencies cannot be directly predicted from the strength of the splice site detected in any particular combination. Sites that appeared to be strong-that is, they outcompeted the others-in one combination were weak-they were outcompeted-in another that differed from the first in a single splice site. (20, 21, 26, 27 Contrary to the result obtained with a-TM exons 2 and 3 (53), the mutual exclusivity of the MLC1/3 exons is not due to steric hindrance problems. However, the underlying principle in the regulated splicing of the two genes appears to be similar. It is based on a lower efficiency of splicing between the two splice sites in the intron than between each of them and the common flanking splice sites. This low efficiency is absolute in the case of the a-TM gene and only relative in the MLC1/3 gene. In both cases, the choice of spliced exon is the result of competition between the two exons for the common flanking sites. Surprisingly, for the MLC1/3 gene, this competition does not require the presence of the intact natural intron between the mutually exclusive exons. It persists when the position of the exons is reversed and, therefore, the intron is disrupted. The lack of steric hindrance as a mechanism to enforce the mutually exclusive splicing of two exons is not unique to MLC1/3. The BPSs between exons 6A and 6B of the chicken P-TM (24; E. Brody, personal communication), between exons 6 and 7 of the rat p-TM gene (19) , and between exons 7 and 8 of the rat a-TM gene (Sengupta and Nadal-Ginard, unpublished data) have been located far upstream from the acceptor AG. None of these, however, is close enough to the 5' splice site to block splicing. Moreover, except for the rat p-TM, these exons are also able to be spliced together in the absence of other competing splice sites.
DISCUSSION
The most surprising aspect of the results presented here is that the behavior of a given splice site is not intrinsic to the site but determined in a significant manner by the other (62) . Surprisingly, however, only 3.6% of splice sites have perfect complementarity to Ul (34) . Moreover, the best match to the consensus sequence is frequently but not always the site used (79%) (37) . These facts are surprising and raise the question of whether a match to the consensus sequence is the main determinant of 5' splice site performance. If this were the case, it would be expected that through evolution most splice sites would have evolved a perfect complementarity to the Ul hybridizing sequence, as is the case in Saccharomyces cerevisiae. Yet, a significant body of experimental data indicates that degree of match to the consensus sequence is directly correlated with both efficiency of Ul binding and strength in cis-competition assays, as determined by their ability to successfully compete for other sites (7, 32, 36, 42, 65) . Sequence context and proximity to the 3' splice site are also important determinants of 5' splice site performance (36, 42) . When sites are placed in similar contexts, the site with the highest homology to the consensus sequence and/or most proximal to the 3' end of the intron is the one preferentially used. The results obtained with the MLC1/3 exons can not be easily explained from what is currently known about the determinants of splice site selection. Either there are additional cis elements or there is additional information in the known ones that is involved in determining splice site behavior. Homology to the consensus sequence does not explain the results observed. The 5' splice site of exon 3 is the closest to the consensus sequence (eight out of nine residues are homologous). However, it is outcompeted by each of the five 5' exons tested in its ability to splice to exon 4 or to any other exon. A similar observation can be made about the behavior of the 5' and 3' splice sites of exon 4. In all but one of the constructs tested the splice sites of this exon are strongerthat is, are preferred-than those of exon 3. Yet in most constructs this exon is outcompeted by the flanking common exons that have splice sites with less homology to the consensus sequence and are located more distally. In the presence of MLC exon 2, it is even weaker than exon 3. Therefore, there are clear preferences in splice-site pairing. A given 5' splice site will select among several acceptor sites, and vice versa, in a manner that is determined neither by proximity nor by homology to the consensus sequence. These results uncover the existence of unsuspected cooperative interactions between 5' and 3' splice sites that appear to be site specific.
A number of reports have demonstrated that exon sequences other than the 5' and 3' splice sites can affect efficiency (12, 18, 30, 42, 59) . Although it is possible that the results reported here are due to sequences other than the canonical cis elements known to be involved in intron removal, this seems unlikely for several reasons. First, there is no significant homology between the sequences contained in the DNA fragments used as the 5' exon from a-TM, MLC1, and insulin. These sequences were randomly chosen, yet all behaved in a similar manner when tested with the same downstream sequences. Second, the changes in splicing pattern observed with different 3' terminal exons were not directly correlated with the exon per se but were dependent on the exon at the 5' end. Third, our preliminary results indicate that the behavior of the constructs can be modified by substituting one 5' splice site sequence for another (unpublished observations).
The results obtained with the MLC1/3 constructs are better explained by the existence of a hierarchy of affinities among 5' and 3' splice sites, with each pair defining a specific interaction. A biochemical explanation for this specificity will have to await an in vitro dissection of these splice sites and their interaction with the splicing trans-acting factors. Despite this lack of information, there is increasing evidence of cooperative interaction between the 5' and 3' splice sites (60) . Recent results (23, 44, 49, 60, 66) have suggested that Ul small nuclear ribonucleoprotein may interact with the splice sites at both ends of the intron early in the splicing reaction and probably plays a role in the commitment of splice sites. The data presently available do not indicate whether there are sequence requirements for this interaction in addition to generic 5' and 3' splice sites. The polypyrimidine track downstream from the BPS plays a role in these interactions (55) , because changes in its pyrimidine content affect the selection between alternative 5' splice sites (11, 59) .
The mechanistic basis for the results discussed here is not readily apparent. The differential affinities observed between specific pairs of splice sites could be caused by the variable nature of the interactions between splicing factors and splice sites, which in turn could be due to the loose conservation of the consensus splicing elements. The formation of spliceosomes involving particular pairs of splice sites may therefore be the result of higher-affinity interactions between the splicing factors initially bound at these pairs of sites. The basis for such cooperative interactions between specific splice site pairs remains to be determined. However, it should be remembered that our understanding of the basic mechanisms of splicing has been derived mainly from simple pre-mRNA substrates, in which the kind of complex interactions observed here would not have been detected.
